View All Documents & Correspondence
Novel Arthritis Emulgel Composition And Its Preparation Process
Abstract: The present invention relates to the novel topical composition of arthritis emulgel. The present invention specifically relates to novel topical composition of arthritis emulgel comprising combination of active ingredients and pharmaceutically acceptable excipients. The present invention more specifically relates to novel composition of arthritis emulgel comprising combination of Curcumin (using Force C3TM augmented absorption technology), Boswellia serrata extract, Methyl salicylate, Menthol as active ingredients and pharmaceutically acceptable excipients. The present invention more specifically relates to novel composition, wherein composition optionally contains one or more of Ginger extract, Glucosamine sulphate and Chondroitin sulphate. The present invention also relates to process for the preparation of novel topical composition of arthritis emulgel comprising the steps of dissolving, mixing, adding, sonicating, adjusting the pH and stirring.
Notices, Deadlines & Correspondence
Patent Information
Applicants
LYRUS LIFE SCIENCES PVT LTD
NOKHA TRADING LLP
Inventors
1. BOTHRA, Chandanmal Pukhraj
2. BOTHRA, Hemanth Kumar
3. NATARAJAN, Elayaraja
4. AGNES JOSE, Jyolsna
5. THAKUR, Shailendra
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202347049507-STATEMENT OF UNDERTAKING (FORM 3) [22-07-2023(online)].pdf | 2023-07-22 |
| 2 | 202347049507-PRIORITY DOCUMENTS [22-07-2023(online)].pdf | 2023-07-22 |
| 3 | 202347049507-POWER OF AUTHORITY [22-07-2023(online)].pdf | 2023-07-22 |
| 4 | 202347049507-FORM 1 [22-07-2023(online)].pdf | 2023-07-22 |
| 5 | 202347049507-DECLARATION OF INVENTORSHIP (FORM 5) [22-07-2023(online)].pdf | 2023-07-22 |
| 6 | 202347049507-COMPLETE SPECIFICATION [22-07-2023(online)].pdf | 2023-07-22 |
| 7 | 202347049507-Proof of Right [02-08-2023(online)].pdf | 2023-08-02 |
| 8 | 202347049507-FORM 3 [12-01-2024(online)].pdf | 2024-01-12 |
| 9 | 202347049507-FORM-26 [19-01-2024(online)].pdf | 2024-01-19 |
| 10 | 202347049507-FORM 18A [24-04-2024(online)].pdf | 2024-04-24 |
| 11 | 202347049507-FER.pdf | 2024-06-19 |
| 12 | 202347049507-FORM 3 [13-08-2024(online)].pdf | 2024-08-13 |
| 13 | 202347049507-OTHERS [19-12-2024(online)].pdf | 2024-12-19 |
| 14 | 202347049507-FER_SER_REPLY [19-12-2024(online)].pdf | 2024-12-19 |
| 15 | 202347049507-CORRESPONDENCE [19-12-2024(online)].pdf | 2024-12-19 |
| 16 | 202347049507-COMPLETE SPECIFICATION [19-12-2024(online)].pdf | 2024-12-19 |
| 17 | 202347049507-CLAIMS [19-12-2024(online)].pdf | 2024-12-19 |
| 18 | 202347049507-US(14)-HearingNotice-(HearingDate-14-02-2025).pdf | 2025-01-24 |
| 19 | 202347049507-Correspondence to notify the Controller [10-02-2025(online)].pdf | 2025-02-10 |
| 20 | 202347049507-MARKED COPIES OF AMENDEMENTS [13-02-2025(online)].pdf | 2025-02-13 |
| 21 | 202347049507-FORM 13 [13-02-2025(online)].pdf | 2025-02-13 |
| 22 | 202347049507-AMMENDED DOCUMENTS [13-02-2025(online)].pdf | 2025-02-13 |
| 23 | 202347049507-US(14)-ExtendedHearingNotice-(HearingDate-27-02-2025)-1530.pdf | 2025-02-17 |
| 24 | 202347049507-Correspondence to notify the Controller [21-02-2025(online)].pdf | 2025-02-21 |
| 25 | 202347049507-Written submissions and relevant documents [13-03-2025(online)].pdf | 2025-03-13 |
| 26 | 202347049507-Annexure [13-03-2025(online)].pdf | 2025-03-13 |
| 27 | 202347049507-FORM 4 [16-10-2025(online)].pdf | 2025-10-16 |
Search Strategy
| 1 | SEARCHSTRATEGYE_12-06-2024.pdf |
| 2 | NA4360E_12-06-2024.pdf |
| 3 | MA3149E_12-06-2024.pdf |
| 4 | GP0453GE_12-06-2024.pdf |
| 5 | BS05449E_12-06-2024.pdf |
| 6 | AT324E_12-06-2024.pdf |
| 7 | AH52664E_12-06-2024.pdf |